AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
United States of America -- The manufacturer of filgrastim (Neupogen[R]) 300 [micro]g vials in ten-pack boxes has reported the existence of a counterfeit product. Neupogen is primarily used to prevent infection, as manifested by febrile neutropenia in cancer patients receiving myelotoxic chemotherapy.
The counterfeit vials examined contain a clear liquid but no active ingredient. This counterfeit …